TODAY'S TOP STORIES
FONT-SIZE Plus   Neg
Share SHARE

J&J Recalls Infants' Tylenol Over Bottle Design

Johnson & Johnson (JNJ: Quote) voluntarily recalled all infant Tylenol in United States, after receiving few complaints from parents who reported difficulty using the Infants' TYLENOL SimpleMeasure dosing system.

J&J's McNeil Consumer Healthcare unit recalled seven lots, about 574,000 bottles of grape-flavored Infants Tylenol from stores nationwide on Friday. TYLENOL is an over-the-counter product indicated as a pain reliever/fever reducer. Children's TYLENOL products are intended for children two years of age and older and remain available.

SimpleMeasure includes a dosing syringe, which a parent or caregiver inserts into a protective cover, or flow restrictor, at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe. No adverse events associated with this action have been reported to date and the risk of a serious adverse medical event is remote. Consumers can continue to use Infants' TYLENOL provided the flow restrictor at the top of the bottle remains in place. If the flow restrictor is pushed into the bottle, the parent or caregiver should not use the product.

The company said customers can continue to use the infant Tylenol if the bottle's flow restrictor remains intact. If not, they can request a refund by contacting McNeil at 1-888-222-6036 or www.tylenol.com.

Since 2009, the company's McNeil Consumer Healthcare recalled several over-the-counter or OTC, medicines, including Tylenol, Benadryl, Motrin, Zyrtec, Sudafed, Sinutab and Rolaids. The recalls prompted J&J to shut down a factory and have cost it more than $1 billion in lost sales.

JNJ closed Friday's regular trading session at $64.99, up $0.07. In after-hours trading, the shares further rose 0.06% to and ended at $65.03.

Register
To receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.